| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/09/2009 | WO2009085216A2 Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease |
| 07/09/2009 | WO2009055922A8 Labeled iodinated tropane formulation |
| 07/09/2009 | US20090175788 Radiolabelled ligand for the glycine 1 transporter |
| 07/09/2009 | US20090175787 Use of fructose-based compounds for the diagnosis of cancer |
| 07/09/2009 | US20090175786 Gastrin Releasing Peptide Compounds |
| 07/09/2009 | US20090175785 Self-Assembled Fmoc-Ff Hydrogels |
| 07/09/2009 | US20090175784 Anti-Alpha V Immunoliposome Composition, Methods, and Uses |
| 07/09/2009 | US20090175783 Compounds and imaging methods |
| 07/09/2009 | DE102007059314A1 Verfahren zur Herstellung von Vorläufern für L-2-[18F]Fluor-phenylalanin und -[18F]Fluor-L-meta-tyrosin und deren α-methylierten Derivaten, Vorläufer, so e Verfahren zur Herstellung von L-2-[18F]Fluor-phenylalanin und 6-[18F]Fluor L-meta-tyrosin und deren α-methylierten Derivaten aus dem Vorläufer Process for the preparation of precursors for L-2- [18F] fluoro-phenylalanine and - [18F] fluoro-L-meta-tyrosine and the α-methylated derivatives, precursors, as e process for the preparation of L-2- [18F] fluoro-phenylalanine and 6- [18F] fluoro-L meta-tyrosine and the α-methylated derivatives from the precursor |
| 07/09/2009 | CA2710984A1 Treatment and prophylaxis of amyloidosis |
| 07/08/2009 | EP2076292A2 Contrast agents for detecting prostate cancer |
| 07/08/2009 | EP1691847A4 Tame based chelators and uses thereof |
| 07/08/2009 | CN101478991A Tc-99m nano tin colloid and preparation thereof |
| 07/08/2009 | CN101474415A RGD polypeptide radiopharmaceutical for integrin alphav beta3 positive tumor and preparation method thereof |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/07/2009 | USRE40837 Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent |
| 07/07/2009 | US7557080 Bacillus Cry9 family members |
| 07/07/2009 | US7556927 Methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/07/2009 | US7556795 Radiopharmaceutical formulations |
| 07/07/2009 | US7556794 Pendant fatty acid imaging agents |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2400994C Radioactive therapeutic liposomes |
| 07/02/2009 | WO2009081287A2 Polysaccharide nanoparticles |
| 07/02/2009 | WO2009080810A1 New polypeptides having affinity for her2 |
| 07/02/2009 | WO2009080561A1 Selective radiolabeling of biomolecules |
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | US20090169498 Controlled Release Gels |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | US20090169475 Radiolabeled derivatives of potent chymase inhibitors |
| 07/02/2009 | US20090169474 Method for noninvasnely and quantitatively monitoring therapeutic and diagnostic transgene expression induced by ex vno and in vno gene targeting in organs, tissues and cells |
| 07/02/2009 | US20090169473 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 07/02/2009 | US20090169472 Methods and compositions for treating immune disorders |
| 07/02/2009 | US20090169471 Particles for injection and processes for forming the same |
| 07/02/2009 | CA2710016A1 Translocator protein ligands |
| 07/02/2009 | CA2709915A1 New polypeptides having affinity for her2 |
| 07/02/2009 | CA2705134A1 Selective radiolabeling of biomolecules |
| 07/01/2009 | EP2074135A2 Silicon derivatives for pet imaging |
| 07/01/2009 | EP2073851A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 07/01/2009 | EP1613610B1 Benzo 1,2,5 oxadiazoles and benzo 1,2,5 thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 07/01/2009 | EP1583564B1 Improved linkers for radiopharmaceutical compounds |
| 07/01/2009 | EP1511721B1 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | CN101472616A Methods of making and using rubidium-81 containing compositions |
| 07/01/2009 | CN101472615A Radiopharmaceutical products |
| 07/01/2009 | CN101472614A Radiolabelling methods |
| 07/01/2009 | CN100506287C Method for preparing radioactive arsenic compound and usage for curing tumor |
| 06/30/2009 | US7553953 For the treatment and diagnosis of various cancers including carcinoma, gastrointestinal, colorectal, colon or ovarian cancer; colon-specific antigen-p mucin (CSAp) antigen |
| 06/30/2009 | US7553486 Anti-VEGF treatment for radiation-induced vasculopathy |
| 06/30/2009 | CA2206274C Radiolabeled annexin-galactose cluster conjugates |
| 06/25/2009 | WO2009079024A1 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
| 06/25/2009 | WO2009077599A2 Nanospheres with external surface of noble metal |
| 06/25/2009 | WO2009077586A2 Methods and compositions for the preparation and use of toxin conjugates |
| 06/25/2009 | WO2009053644A3 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 06/25/2009 | US20090163405 Angiogenic peptides and uses thereof |
| 06/25/2009 | US20090162293 Methods and compositions for ultrasound imaging of apoptosis |
| 06/25/2009 | US20090162283 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/25/2009 | US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | US20090162281 Radionuclide labeling of Vitamin B12 and Co-enzymes thereof |
| 06/25/2009 | US20090162280 Detecting soluble a-beta |
| 06/25/2009 | US20090162279 Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm |
| 06/25/2009 | US20090162278 Method for Production of Radioisotope Preparations and Their Use in Life Science, Research, Medical Application and Industry |
| 06/25/2009 | US20090162277 Lysophospholipids Solubilized Single-Walled Carbon Nanotubes |
| 06/25/2009 | US20090162276 Medical devices containing melt-blown non-wovens of poly-4-hydroxybutyrate and copolymers thereof |
| 06/25/2009 | US20090162275 Contrast agents anchored by thiols on nanoparticles |
| 06/25/2009 | CA2696260A1 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
| 06/24/2009 | EP2072525A1 New polypeptides having affinity for HER2 |
| 06/24/2009 | EP1706145B1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 06/24/2009 | CN101461950A Disposal reagent kit and automatic chemosynthesis main machine |
| 06/23/2009 | US7550569 Antibodies that specifically bind to GMAD |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550423 Modulate hormone release; controlling neurotransmitter release |
| 06/23/2009 | US7550272 Method for diagnosis of pancreatic exocrine function |
| 06/23/2009 | US7550141 Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids |
| 06/23/2009 | US7550140 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 06/23/2009 | US7550005 Coated implantable medical device |
| 06/23/2009 | CA2402991C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 06/18/2009 | WO2009076434A1 Inhibitors of integrin vla-4 |
| 06/18/2009 | WO2009073984A1 High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles |
| 06/18/2009 | US20090156848 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 06/18/2009 | US20090156668 Ginkgolide Compounds, Compositions, And Extracts, And Uses Thereof |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155170 Annexin derivatives suitable for pretargeting in therapy and diagnosis |
| 06/18/2009 | US20090155169 Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof |
| 06/18/2009 | US20090155168 radiolabelled amidine derivatives such as N-(3,5-dichlorobenzyl)-4-iodophenyl amidine suitable for imaging with tomography; selective antagonists of N-methylaspartic acid receptors, used for the diagnosis of pain, epilepsy, stroke, ischemia, spasms, neurodegenerative and psychological disorders |
| 06/18/2009 | US20090155167 Automated method |
| 06/18/2009 | US20090155166 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules |
| 06/18/2009 | US20090155165 Anti-igf-i receptor antibody |
| 06/18/2009 | US20090155164 Human c-fms antigen binding proteins |
| 06/18/2009 | DE102007059313A1 Verfahren zur Herstellung von Vorläufern für L-3,4-Dihydroxy-6-[18F]fluor-phenylalanin und 2-[18F]Fluor-L-tyrosin und deren α-methylierten Derivaten, Vorläufer, sowie Verfahren zur Herstellung von L-3,4-Dihydroxy-6-[18F]fluor-phenylalanin und 2-[18F]Fluor-L-tyrosin und deren α-methylierten Derivaten aus dem Vorläufer Process for the preparation of precursors for L-3,4-dihydroxy-6- [18F] fluoro-phenylalanine and 2- [18F] fluoro-L-tyrosine and the α-methylated derivatives, precursors, as well as methods for the production of L-3 , 4-dihydroxy-6- [18F] fluoro-phenylalanine and 2- [18F] fluoro-L-tyrosine and the α-methylated derivatives from the precursor |
| 06/18/2009 | CA2708719A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles |
| 06/17/2009 | EP2070548A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 06/17/2009 | EP2068975A2 Catheter and array for anticancer therapy |
| 06/17/2009 | EP2068942A2 Radiopharmaceutical to be used in distinction between inflammations and infections in orthopaedic implants |
| 06/17/2009 | EP0975595B1 Analogs of cocaine |
| 06/16/2009 | US7547441 PAI-2 conjugates for the treatment and imaging of cancer |
| 06/16/2009 | CA2334810C Method and device for delivery of therapeutic agents in conjunction with isotope seed placement |
| 06/16/2009 | CA2264750C Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 06/11/2009 | WO2009073698A1 Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients |